Osaka, Japan

Tokushige Nakano

This inventor holds 10 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents and 7 EPO patents. Top assignees: Sumitomo Chemical Company, Limited, Riken Corporation. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tokushige Nakano. Retrieved from https://idiyas.com/inventor/tokushige-nakano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Tokushige Nakano

Introduction

Tokushige Nakano is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the production of retinal tissue and related cells. With a total of eight patents to his name, Nakano's work has the potential to impact the treatment of retinal diseases.

Latest Patents

One of Nakano's latest patents is a method for producing retinal tissue and retina-related cells. This invention outlines a two-step process that begins with subjecting pluripotent stem cells to floating culture in a serum-free medium to form an aggregate. The second step involves further culturing this aggregate in a medium that is free of substances acting on the Sonic hedgehog signal transduction pathway but contains substances acting on the BMP signal transduction pathway. This innovative approach aims to obtain aggregates containing retinal progenitor cells.

Another notable patent is the method for producing a ciliary marginal zone-like structure. This invention describes a process for culturing a cell aggregate containing retinal tissue, where Chx10 positive cells are present in a significant proportion. The method emphasizes the importance of using a serum-free medium or serum-containing medium that acts on the Wnt signal pathway for a limited time, followed by a different culturing approach to achieve the desired cell structure.

Career Highlights

Throughout his career, Tokushige Nakano has worked with esteemed organizations such as Sumitomo Chemical Company, Limited and Riken Corporation. His experience in these companies has allowed him to develop and refine his innovative techniques in cell culture and regenerative medicine.

Collaborations

Nakano has collaborated with notable colleagues in his field, including Yoshiki Sasai and Chikafumi Ozone. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Tokushige Nakano's contributions to the field of regenerative medicine through his innovative patents highlight his role as a leading inventor. His work in producing retinal tissue and related structures has the potential to transform treatment options for retinal diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…